Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine

por Shirayama, Yukihiko, Hashimoto, Kenji
Publicado 2017

Circulating Neuroactive Steroid Levels in a Patient With Schizophrenia Who Showed Periodic Catatonia

por Muneoka, Katsumasa, Shirayama, Yukihiko, Watanabe, Hiroyuki, Kimura, Hiroshi
Publicado 2023

Effects of Add-on Ramelteon on Cognitive Impairment in Patients with Schizophrenia: An Open-label Pilot Trial

por Shirayama, Yukihiko, Takahashi, Michio, Suzuki, Masatoshi, Tsuruoka, Yoshiaki, Sato, Koichi
Publicado 2014

Utility of the Neurobehavioral Cognitive Status Examination (COGNISTAT) in differentiating between depressive states in late-life depression and late-onset Alzheimer’s disease: a p...

por Tsuruoka, Yoshiaki, Takahashi, Michio, Suzuki, Masatoshi, Sato, Koichi, Shirayama, Yukihiko
Publicado 2016

Cognitive behavioral therapy for postpartum panic disorder: a case series

por Matsumoto, Kazuki, Sato, Koichi, Hamatani, Sayo, Shirayama, Yukihiko, Shimizu, Eiji
Publicado 2019

Regional Differences in Brain-Derived Neurotrophic Factor Levels and Dendritic Spine Density Confer Resilience to Inescapable Stress

por Yang, Chun, Shirayama, Yukihiko, Zhang, Ji-chun, Ren, Qian, Hashimoto, Kenji
Publicado 2015

Personality Traits as Risk Factors for Treatment-Resistant Depression

por Takahashi, Michio, Shirayama, Yukihiko, Muneoka, Katsumasa, Suzuki, Masatoshi, Sato, Koichi, Hashimoto, Kenji
Publicado 2013

Low Openness on the Revised NEO Personality Inventory as a Risk Factor for Treatment-Resistant Depression

por Takahashi, Michio, Shirayama, Yukihiko, Muneoka, Katsumasa, Suzuki, Masatoshi, Sato, Koichi, Hashimoto, Kenji
Publicado 2013

A Study of Remitted and Treatment-Resistant Depression Using MMPI and Including Pessimism and Optimism Scales

por Suzuki, Masatoshi, Takahashi, Michio, Muneoka, Katsumasa, Sato, Koichi, Hashimoto, Kenji, Shirayama, Yukihiko
Publicado 2014

Associations among autistic traits, cognitive and affective empathy, and personality traits in adults with autism spectrum disorder and no intellectual disability

por Shirayama, Yukihiko, Matsumoto, Kazuki, Hamatani, Sayo, Muneoka, Katsumasa, Okada, Akihiro, Sato, Koichi
Publicado 2022

Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects

por Fukami, Goro, Hashimoto, Tasuku, Shirayama, Yukihiko, Hasegawa, Tadashi, Watanabe, Hiroyuki, Fujisaki, Mihisa, Hashimoto, Kenji, Iyo, Masaomi
Publicado 2010

Abnormal composition of gut microbiota is associated with resilience versus susceptibility to inescapable electric stress

por Zhang, Kai, Fujita, Yuko, Chang, Lijia, Qu, Youge, Pu, Yaoyu, Wang, Siming, Shirayama, Yukihiko, Hashimoto, Kenji
Publicado 2019

Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation

por Zhang, Ji-chun, Wu, Jin, Fujita, Yuko, Yao, Wei, Ren, Qian, Yang, Chun, Li, Su-xia, Shirayama, Yukihiko, Hashimoto, Kenji
Publicado 2015

Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T (1)H-MRS Study

por Matsuzawa, Daisuke, Obata, Takayuki, Shirayama, Yukihiko, Nonaka, Hiroi, Kanazawa, Yoko, Yoshitome, Eiji, Takanashi, Junichi, Matsuda, Tsuyoshi, Shimizu, Eiji, Ikehira, Hiroo, Iyo, Masaomi, Hashimoto, Kenji
Publicado 2008

Author Correction: Increased EphA4-ephexin1 signaling in the medial prefrontal cortex plays a role in depression-like phenotype

por Zhang, Ji-chun, Yao, Wei, Qu, Youge, Nakamura, Mayumi, Dong, Chao, Yang, Chun, Ren, Qian, Ma, Min, Han, Mei, Shirayama, Yukihiko, Hayashi-Takagi, Akiko, Hashimoto, Kenji
Publicado 2023

Increased EphA4-ephexin1 signaling in the medial prefrontal cortex plays a role in depression-like phenotype

por Zhang, Ji-chun, Yao, Wei, Qu, Youge, Nakamura, Mayumi, Dong, Chao, Yang, Chun, Ren, Qian, Ma, Min, Han, Mei, Shirayama, Yukihiko, Hayashi-Takagi, Akiko, Hashimoto, Kenji
Publicado 2017

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia

por Shiina, Akihiro, Shirayama, Yukihiko, Niitsu, Tomihisa, Hashimoto, Tasuku, Yoshida, Taisuke, Hasegawa, Tadashi, Haraguchi, Tadashi, Kanahara, Nobuhisa, Shiraishi, Tetsuya, Fujisaki, Mihisa, Fukami, Goro, Nakazato, Michiko, Iyo, Masaomi, Hashimoto, Kenji
Publicado 2010

Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses

por Yamanashi, Takehiko, Iwata, Masaaki, Kamiya, Naho, Tsunetomi, Kyohei, Kajitani, Naofumi, Wada, Nodoka, Iitsuka, Takahiro, Yamauchi, Takahira, Miura, Akihiko, Pu, Shenghong, Shirayama, Yukihiko, Watanabe, Ken, Duman, Ronald S., Kaneko, Koichi
Publicado 2017

Prefrontal cortex infusion of beta‐hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant‐like effects in a rodent model of depression

por Kajitani, Naofumi, Iwata, Masaaki, Miura, Akihiko, Tsunetomi, Kyohei, Yamanashi, Takehiko, Matsuo, Ryoichi, Nishiguchi, Tsuyoshi, Fukuda, Saki, Nagata, Mayu, Shibushita, Midori, Yamauchi, Takahira, Pu, Shenghong, Shirayama, Yukihiko, Watanabe, Ken, Kaneko, Koichi
Publicado 2020

Beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, attenuates anxiety-related behavior in a rodent post-traumatic stress disorder model

por Yamanashi, Takehiko, Iwata, Masaaki, Shibushita, Midori, Tsunetomi, Kyohei, Nagata, Mayu, Kajitani, Naofumi, Miura, Akihiko, Matsuo, Ryoichi, Nishiguchi, Tsuyoshi, Kato, Takahiro A., Setoyama, Daiki, Shirayama, Yukihiko, Watanabe, Ken, Shinozaki, Gen, Kaneko, Koichi
Publicado 2020